Evidence map›Paper›PMID 25690893›Full record

ArticleNucleic acids research2015

Highly efficient CRISPR/Cas9-mediated TAR cloning of genes and chromosomal loci from complex genomes in yeast.

Nicholas C O Lee, Vladimir Larionov, Natalay Kouprina

Abstract read
In one paragraph

Article in Nucleic acids research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed.

  1. Article
  2. Review
  3. Multi-Targeting Non-Specific Genome Engineering in Bacteria.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  4. iCASRED, a scarless DNA editing tool inSynthetic and systems biotechnology · 2025
    Article
  5. Article
  6. Current Approaches for Genetic Manipulation ofBiotech (Basel (Switzerland)) · 2025
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Cross-species microbial genome transfer: a Review.Frontiers in bioengineering and biotechnology · 2023
    Review
  20. Review

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nicholas C O LeeDevelopmental Therapeutics Branch, National Cancer Institute, Bethesda, MD 20892, USA.
Vladimir LarionovDevelopmental Therapeutics Branch, National Cancer Institute, Bethesda, MD 20892, USA.
Natalay KouprinaDevelopmental Therapeutics Branch, National Cancer Institute, Bethesda, MD 20892, USA kouprinn@mail.nih.gov.

Funding

Intramural NIH HHS
6 · The paper itself

Abstract

Transformation-associated recombination (TAR) protocol allowing the selective isolation of full-length genes complete with their distal enhancer regions and entire genomic loci with sizes up to 250 kb from complex genomes in yeast S. cerevisiae has been developed more than a decade ago. However, its wide spread usage has been impeded by a low efficiency (0.5-2%) of chromosomal region capture during yeast transformants which in turn requires a time-consuming screen of hundreds of colonies. Here, we demonstrate that pre-treatment of genomic DNA with CRISPR-Cas9 nucleases to generate double-strand breaks near the targeted genomic region results in a dramatic increase in the fraction of gene-positive colonies (up to 32%). As only a dozen or less yeast transformants need to be screened to obtain a clone with the desired chromosomal region, extensive experience with yeast is no longer required. A TAR-CRISPR protocol may help to create a bank of human genes, each represented by a genomic copy containing its native regulatory elements, that would lead to a significant advance in functional, structural and comparative genomics, in diagnostics, gene replacement, generation of animal models for human diseases and has a potential for gene therapy.

Indexed as

CRISPR-Cas SystemsGenesCell Cycle ProteinsChromosomes, FungalCloning, MolecularEndodeoxyribonucleasesGenetic LociGenome, FungalHumansNuclear ProteinsRecombination, GeneticRNASaccharomyces cerevisiaeCell Cycle ProteinsEndodeoxyribonucleasesNBN protein, humanNuclear ProteinsRNA

Identifiers

PMID25690893
PMCPMC4417148

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.